So far, four variants of SARS-CoV-2 have been identified as "variants of concern" by the World Health Organization: Alpha, Beta, Gamma, and Delta, which is the most recent addition to the list.

These variants are shown to be either more contagious, more deadly, or more resistant to current treatments.But of the four, Delta is especially concerning.

According to the WHO, it's the "fastest and fittest" variant yet. It has soon replaced Alpha as the dominant variant worldwide. It impacts our health in different ways.

We use all the available tools to combat the outbreak, in the process, targeted detection appears to be very important.

Recently, the SARS-CoV-2 Delta variant Detection Kit (Real-Time PCR Method) and SARS-CoV-2 variants Detection Kit (Real-Time PCR Method) of Mabsky Co., Ltd. has been approved by CE. The Kits are used to qualitative detect SARS-COV-2 variants including Delta, Delta-plus , Beta, Gamma, Epsilon, Kappa etc. in nasopharyngeal swab and oropharyngeal swabs specimens from the patients with signs and symptoms of infection with SARS-COV-2. The kits provides accurate, rapid and effective identification for the current variants. Thus, provide strong support for COVID-19 detection and prevention.